• First FDA-approved, at-home screening test that uses RNA technology to detect biomarkers associated with colorectal cancer and advanced adenomas
  • Designed to reduce common barriers to at-home screening with a cleaner, simplified collection experience that minimizes sample handling
  • Meets screening guidelines from the American Cancer Society (ACS) and National Comprehensive Cancer Network (NCCN)